Fusarium fingernail infection responsive to fluconazole intermittent therapy

Cutis

Volumn 65, Issue 6, 2000, Pages 352-354

  Tseng, Stephanie S ^a,b   Longley, B Jack ^a,b   Scher, Richard K ^a,b   Treiber, Ruth Kaplan ^a,b,c  

^a Department of Orthopaedic Surgery   (United States)

^b Columbia University ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ARTICLE; CASE REPORT; DRUG ADMINISTRATION; FEMALE; FUSARIUM; HAND DISEASE; HUMAN; ONYCHOMYCOSIS; PATHOLOGY;

ADULT; ANTIFUNGAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUCONAZOLE; FUSARIUM; HAND DERMATOSES; HUMANS; ONYCHOMYCOSIS;

EID: 0034200296     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ramani R, Srinivas CR, Ramani A, et al: Molds in onychomycosis. Int J Dermatol 32: 877-878, 1993.
2. Elewski BE, Charif MA, Daniel CR: Onychomycosis, In, Nails: Therapy-Diagnosis-Surgery (Scher RK, Daniel CR, eds), pp 151-162. Philadelphia, WB Saunders, 1997.
3. DiSalvo AF, Fickling AM: A case of nondermatophytic toe onychomycosis caused by Fusarium oxysparum. Arch Dermatol 116: 699-700, 1980.
4. Nelson PE, Dignani MC, Anaissie EJ: Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 7(4): 479-500, 1994.
5. Arrese JE, Pierard-Franchimont C, Pierard GE: Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopath 18(2): 196-198, 1996.
6. Baran R, Tosti A, Piraccini BM: Uncommon clinical patterns of Fusarium nail infection: report of three cases. Br J Dermatol 136: 424-427, 1997.
7. Gianni C, Cerri A, Crosti C: Unusual clinical features of fingernail infection by Fusarium oxysporum. Mycoses 40: 455-459, 1997.
8. Liu K, Howell DN, Perfect JR, et al: Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 109: 45-54, 1998.
9. Hochman LG, Scher RK, Myerson MS, et al: The safety and efficacy of oral fluconazole in the treatment of onychomycosis. J Geriatric Dermatol 1: 169-172, 1993.
10. Scher RK, Breneman D, Rich P, et al: Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol 38 (6 pt. 2): S77-S86, 1998.
11. Pujol I, Guarro J, Gene J, Sala J: In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother 39: 163-167, 1997.
12. Speeleveld E, Gordts B, Van Landuyt HW, et al: Susceptibility of clinical isolates of Fusarium to antifungal drugs. Mycoses 39: 37-40, 1996.
13. De Doncker PR, Scher RK, Baran RL, et al: Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. J Am Acad Dermatol 36: 173-177, 1997.